Wed, Aug 27, 2014, 9:22 AM EDT - U.S. Markets open in 8 mins.


% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • investormdpart2 investormdpart2 Jan 3, 2013 3:37 PM Flag

    This is why I like NBIX in 2013

    I think they said this on one of their quarterly conference calls...maybe two calls back?? It was just something along the lines of maybe Abbott will mention it and maybe they won't. They didn't know. However, my guess is that AbbVie will mention any positive phase 2 results because they need to drive up their stock price. I'm actually thinking about grabbing some their pipeline. Am a big fan of the Galapagos JAK1 that AbbVie is developing for rheumatoid arthritis.

    AbbVie is basically in a race against time because their cholesterol drug is going off patent and Humira goes off patent in 2017. They are looking for a replacement and if Phase 2 UF data is good then Elagolix could be one of their answers.

    I am a very long term investor also....I was here initially when the focus was on CRF antagonists. That was a long time ago. It's nice to see NBIX resurrected after the insomnia debacle. Only a few companies can rebuild and make it back to the spotlight. I know there have been lots of changes but it's nice to see NBIX as a potential player again.

16.19Aug 26 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.